CAS 769905-89-7

Everolimus Hydrolized Impurity

CAS: 769905-89-7

Fórmula: C₅₃H₈₅NO₁₅

Peso molecular: 976.27

Ref: 4Z-E-1012

seco Everolimus B (~90%)

Producto controlado

CAS: 769905-89-7

Applications seco Everolimus B is a metabolite of Everolimus (E945400); an immunosuppressant macrolide and analog of the parent drug Rapamycin (R124000). Everolimus inhibits cytokine-mediated lymphocyte proliferation.
References Dumont, F.J., et al.: Curr. Opin. Invest. Drugs, 2, 1220 (2001); Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001); Nashan, B., et al.: Ther. Drug Monit., 24, 53 (2002)

Fórmula: C₅₃H₈₅NO₁₅

Pureza: ~90%

Forma y color: Neat

Peso molecular: 976.24

Ref: TR-E945410

Seco everolimus B

CAS: 769905-89-7

Seco everolimus B is a drug product that has not been approved by the FDA. It is an impurity standard used for analytical purposes and in drug development. It is a synthetic, natural, and pharmacopoeia-grade impurity. The CAS number of this product is 769905-89-7. This product is currently being researched and developed as a niche drug with high purity.

Fórmula: C₅₃H₈₅NO₁₅

Pureza: Min. 95%

Peso molecular: 976.24 g/mol

Ref: 3D-UFB90589

Seco Everolimus B

CAS: 769905-89-7

Fórmula: C₅₃H₈₅NO₁₅

Peso molecular: 976.3

Ref: ST-EA-CP-E33013